drugset

drugset / Trial / NCT01135108

Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury

NCT01135108 ↗

Phase 2 Completed 5 enrolled KAI Pharmaceuticals Trident Clinical Research Pty Ltd · collab

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine whether KAI-1678 is effective in the treatment of pain associated with spinal cord injury.

Timeline

Start: 2009-03
Primary completion: 2010-03
Completion: 2010-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KAI-1678	Unknown	—	Subcutaneous

Indications